BrioHealth Solutions
PrivateLast Round
IPO
Dec 26, 2025
Est. Valuation
$580M
Total Funding Raised
$114.73M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BrioHealth Solutions operates in Healthcare & Life Sciences and is based in Burlington, Massachusetts. Its latest recorded funding round was a Series E round in July 2025.
BrioHealth Solutions is a medical technology company that develops the BrioVAD™ System, a left ventricular assist system for patients with advanced heart failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BrioHealth Solutions Comparables
Compare BrioHealth Solutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CorWave | 91% | |
| Evaheart, Inc. | 84% | |
| Abbott Laboratories | 82% |
For institutional investors. Book with your work email.
BrioHealth Solutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Dec 26, 2025 | ||||
| Series E | Jul 21, 2025 | ||||
| Series D Extension | Jan 25, 2022 | ||||
| Series D | Aug 13, 2021 | ||||
| Series C | Dec 1, 2020 | ||||
Series B | Apr 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BrioHealth Solutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series D Extension |
| Lake Bleu Capital | Series D Extension, Series D |
| Hosencare Brothers | Series D Extension, Series D |
| CITIC Securities | IPO |
| Hosen Capital | Series B, Series D |
| Lingdao Capital | Series D, Series D Extension |
| Leadway Trustees Limited | Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 26, 2025
$157M round led by CITIC Securities Co Ltd
- Jul 20, 2025
$100M round led by Gaorong Capital and Neovision Capital.
For institutional investors. Book with your work email.
BrioHealth Solutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BrioHealth Solutions's valuation, stock price, and market status.
Is BrioHealth Solutions a public or private company?
BrioHealth Solutions is a private company.
What is the current stock price of BrioHealth Solutions?
BrioHealth Solutions is a private company, so its shares have no public market price. Caplight tracks BrioHealth Solutions's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BrioHealth Solutions worth (valuation)?
BrioHealth Solutions's valuation is estimated at $580.0M based on funding round data.
Can I buy BrioHealth Solutions stock?
BrioHealth Solutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BrioHealth Solutions's last funding round?
BrioHealth Solutions's most recent funding round was IPO on December 26, 2025.
Who are the main investors in BrioHealth Solutions?
Key investors in BrioHealth Solutions include HighLight Capital, CITIC Securities, Lingdao Capital, PICC Capital Insurance Asset Management, CICC Capital.
Will BrioHealth Solutions IPO soon?
No public IPO plans have been announced for BrioHealth Solutions.
How can I track BrioHealth Solutions secondary market activity?
Caplight tracks bids, offers, and trades in BrioHealth Solutions's shares on secondary markets.